PM Modi visit Serum Institute Pune oxford vaccine astrazeneca status review

IndiaTV-English News


coronavirus vaccine, oxford vaccine, serum vaccine, pm modi serum institute of india vaccine, corona
Image Source : PTI

PM Modi to visit Pune’s Serum Institute of India on November 28, more likely to review vaccine status

Prime Minister Narendra Modi on Saturday will visit the Serum Institute of India in Pune, which has partnered with international pharma big AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official informed PTI on Thursday.

“We have received a confirmation about PM Modi’s visit to the Serum Institute of India on Saturday, but his minute-to-minute program is yet to be received,” Pune Divisional Commissioner Saurabh Rao was quoted, as saying.

Rao mentioned there was a risk of the PM’s visit to Pune, and if that occurs, it could be geared toward reviewing the status of the vaccine candidate for coronavirus an infection and to learn about its launch manufacturing and distribution mechanisms.

READ MORE: Serum Institute, Bharat Biotech to begin intranasal coronavirus vaccine trials

Meanwhile, ambassadors and envoys from 100 international locations are additionally slated to visit the Serum Institute of India and the Gennova Biopharmaceuticals Ltd on December 4.

The Central Drug Standard Control Organisation has granted permission for manufacture of coronavirus vaccine for pre-clinical take a look at, exmaination and evaluation to seven companies, two of that are the Serum Institute of India (SII) and the Gennova Biopharmaceuticals.

Meanwhile, the Serum Institute of India and ICMR on Thursday introduced the completion of enrolment means of 1,600 members within the phase-III scientific trials for COVID-19 vaccine Covishield within the nation. SII and the Indian Council of Medical Research (ICMR) are collaborating on the scientific trials of the vaccine within the nation. While ICMR has funded the scientific trial web site charges, SII is taking good care of different bills for the Covishield.

Currently, SII and ICMR are conducting section II/III scientific trial of the vaccine at 15 completely different centres throughout the nation, SII mentioned in a press release.

READ MORE: COVID-19 vaccine may be ready by December, in market by March, says Serum Institute

Latest India News





Source link